Eupraxia Pharmaceuticals Reports Fourth Quarter 2024 Financial Results

Go back to Eupraxia Pharmaceuticals Reports Fourth Quarter 2024 Financial Results
(NASDAQ: EPRX) Delayed: 8.02 --0 (-0%)
Previous Close $8.02    52 Week High
Open $8.02    52 Week Low
Day High $8.02    P/E N/A 
Day Low $8.02    EPS
Volume 50